https://www.selleckchem.com/products/dyngo-4a.html
levels independently predicted the risk of disease progression in patients with NMIBC. However, it was not found to be associated with either RFS or PFS in NMIBC patients based on their EAU risk group. This marker seems to have a limited role in NMIBC at the present time. However, further research is needed to investigate this marker in combination with other systemic inflammatory markers to help improve prediction in this heterogeneous group of patients.Accumulation of the tau protein in fibrillar intracellular aggregates is a definin
Like
Comment
Share
